Eslicarbazepine: clinical use
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Eslicarbazepine: clinical use. Eslicarbazepine is a third generation dibenzazepine. Fully referenced neurology checklist.
Mode of action
- Eslicarbazepine is a third generation dibenzazepine
- It blocks voltage-gated sodium channels (VGSC)
Dosing
Locked: subscribe to see this section.
Indications
Locked: subscribe to see this section.
Systemic side effects
Locked: subscribe to see this section.
Neurological side effects
Locked: subscribe to see this section.
Drugs whose blood levels are reduced by Esclicarbazepine
Locked: subscribe to see this section.
Drugs which reduce Esclicarbazepine blood levels
Locked: subscribe to see this section.
References
- Rocamora R. A review of the efficacy and safety of eslicarbazepine acetate in the management of partial-onset seizures. Ther Adv Neurol Disord 2015; 8:178-186.
- Shirley M, Dhillon S. Eslicarbazepine Acetate Monotherapy: A Review in Partial-Onset Seizures. Drugs 2016; 76:707-717.
- Tambucci R, Basti C, Maresca M, Coppola G, Verrotti A. Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsy. Neuropsychiatr Dis Treat 2016; 12:1251-1260.
- Chaves J, Breia P, Pimentel J, et al. Eslicarbazepine acetate as adjunctive therapy in clinical practice: ESLADOBA study. Acta Neurol Scand 2017; 264:421-431.
- Galiana GL, Gauthier AC, Mattson RH. Eslicarbazepine acetate: a new improvement on a classic drug family for the treatment of partial-onset seizures. Drugs R D 2017; 17:329-339.
- And 2 more. Subscribe to see the full list
